Publication | Open Access
Combined Efficacy of CXCL5, STC2, and CHI3L1 in the Diagnosis of Colorectal Cancer
10
Citations
23
References
2022
Year
STC2 was a promising serum biomarker for CRC diagnosis either used alone or in combination with CXCL5 and CHI3L1.
| Year | Citations | |
|---|---|---|
Page 1
Page 1